1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow defactinib: new trials by email Literature Review of defactinib trials Research Report on defactinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer avutometinib, Defactinib, Pegylated liposomal doxorubicin - Low Grade Serous Ovarian Cancer | Phase 3 | Recruiting | Verastem, Inc. | 270 | 2024-03-18 | 2026-10-07 |
Verastem, Inc. (1)
Australia (1) · Belgium (1) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Ireland (1) · Italy (1) · Japan (1) · Netherlands (1) · New Zealand (1) · Poland (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Rachel Grisham, MD (1) · Susana Banerjee, MBBS, MA, PhD (1)